Dr. Andrew J. Kaufman, an expert in advanced minimally invasive thoracic surgery and thoracic surgical oncology, is the Director of The Thoracic Surgery Airway Program and The Asian Thoracic Surgery Program at Mount Sinai, as well as the Associate Program Director for the Thoracic Surgery Residency Program. He attended New York University School of Medicine for medical school and general surgery training. He completed a two year research fellowship at Memorial Sloan-Kettering Cancer Center and was awarded a national TSFRE Research Fellowship Grant and the Chairman’s Award for Excellence in Basic Science Research.
Dr. Kaufman went on to complete his residency on the Thoracic Surgery track in cardiothoracic surgery, specializing in thoracic surgery, at Memorial Sloan-Kettering Cancer Center/New York Hospital Weill-Cornell Medical Center as the Memorial Fellow in General Thoracic Surgery where he received the Alumni Foundation Award for All-Around Clinical Excellence. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery.
Dr. Kaufman especially enjoys spending time with and getting to know the people he meets in the office and hospital. He is dedicated to the compassionate care of people and their families across all social, economic, and cultural backgrounds. Having lived and studied in China for two years, Dr. Kaufman is fluent in Mandarin and conversational in Cantonese. His background in Asian language and culture inspired the development of the Asian Thoracic Surgery Program at the Mount Sinai. The program focuses on providing the most advanced multidisciplinary care for the Asian community with the goal of integrating community outreach, patient education, and scientific research to provide comprehensive care in this important New York City population.
Dr. Kaufman is clinically focused on advanced minimally invasive and lung sparing surgery for thoracic malignancies. These specialized cancer operations conserve lung tissue and preserve respiratory function with faster recovery times. Andrew has published and presented widely on his lung sparing techniques of Video Assisted Thoracoscopic Surgery (VATS) segmentectomy for early lung cancers as well as pleurectomy and decortication for malignant pleural mesothelioma. His research interests are focused on combining clinical, pathologic, and genetic data to better understand lung cancer in smokers and non-smokers.
Dr. Kaufman works closely with the Interventional Pulmonary Division to locate and mark small early cancers with Navigational Bronchoscopy in order to facilitate VATS lung sparing segmentectomy. This collaboration is also essential to The Thoracic Surgery Airway Program, which focuses on the diagnosis and treatment of benign and malignant diseases of the trachea and airways, such as tracheobronchomalacia and tracheal stenosis, utilizing both surgical and interventional techniques.
In his spare time, Dr. Kaufman enjoys spending time with his wife and two terrific daughters. He is an avid cook, guitarist, and tennis player.
American Board of Surgery
MD, New York University School of Medicine
Residency, Surgery (Gen)
New York University School of Medicine
New York University School of Medicine
Residency, Cardiothoracic Surg
New York Presbyterian - Weill Cornell Medical Center
Fellowship, Thoracic Surgery
Memorial Sloan-Kettering Cancer Center
Chinese (Cantonese), Chinese (Mandarin), English
Kaufman AJ, Flores RM. Surgical treatment of malignant pleural mesothelioma. Current treatment options in oncology 2011 Jun; 12(2).
Shapiro M, Kadakia S, Lim J, Breglio A, Wisnivesky JP, Kaufman A, Lee DS, Flores RM. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer. Chest 2013 Nov; 144(5).
Kaufman AJ, Pass HI. Current concepts in malignant pleural mesothelioma. Expert review of anticancer therapy 2008 Feb; 8(2).
Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B, Teruya-Feldstein J, Tempst P, Pandolfi PP. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 2006 Jul; 126(2).
Bonomi M, Abbott RW, Patsias A, Misiukiewicz K, Demicco EG, Zhang D, Kaufman A, Genden EM, Posner M. Role of Human Papillomavirus and p16 Staining in a Patient With Head and Neck Cancer Presenting With a Synchronous Lung Nodule: A Case Report and Review of the Literature. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Mar;.
Huang G, Kaufman AJ, Ramanathan Y, Singh B. SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex. The Journal of biological chemistry 2011 Mar; 286(12).
Broderick SR, Golas BJ, Pham D, Towe CW, Talbot SG, Kaufman A, Bains S, Huryn LA, Yonekawa Y, Carlson D, Hambardzumyan D, Ramanathan Y, Singh B. SCCRO promotes glioma formation and malignant progression in mice. Neoplasia (New York, N.Y.) 2010 Jun; 12(6).
Kim AY, Bommeljé CC, Lee BE, Yonekawa Y, Choi L, Morris LG, Huang G, Kaufman A, Ryan RJ, Hao B, Ramanathan Y, Singh B. SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. The Journal of biological chemistry 2008 Nov; 283(48).
Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, Kaufman A, Ryan R, Ghossein R, Rao PH, Stoffel A, Ramanathan Y, Singh B. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer research 2006 Oct; 66(19).
Kaufman AJ. Invited commentary. The Annals of thoracic surgery 2011 Aug; 92(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Kaufman did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.